These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22888961)

  • 61. The proto-oncogene PBF binds p53 and is associated with prognostic features in colorectal cancer.
    Read ML; Seed RI; Modasia B; Kwan PP; Sharma N; Smith VE; Watkins RJ; Bansal S; Gagliano T; Stratford AL; Ismail T; Wakelam MJ; Kim DS; Ward ST; Boelaert K; Franklyn JA; Turnell AS; McCabe CJ
    Mol Carcinog; 2016 Jan; 55(1):15-26. PubMed ID: 25408419
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Novel Siglec-15-Sia axis inhibitor leads to colorectal cancer cell death by targeting miR-6715b-3p and oncogenes.
    Ahmad MS; Braoudaki M; Patel H; Ahmad I; Shagufta ; Siddiqui SS
    Front Immunol; 2023; 14():1254911. PubMed ID: 37869015
    [TBL] [Abstract][Full Text] [Related]  

  • 63. PTTG1/ZEB1 Axis Regulates E-Cadherin Expression in Human Seminoma.
    Teveroni E; Di Nicuolo F; Vergani E; Bianchetti G; Bruno C; Maulucci G; De Spirito M; Cenci T; Pierconti F; Gulino G; Bassi P; Pontecorvi A; Milardi D; Mancini F
    Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230799
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nuclear Localization of PTTG1 Promotes Migration and Invasion of Seminoma Tumor through Activation of MMP-2.
    Teveroni E; Di Nicuolo F; Bianchetti G; Epstein AL; Grande G; Maulucci G; De Spirito M; Pontecorvi A; Milardi D; Mancini F
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33430117
    [TBL] [Abstract][Full Text] [Related]  

  • 65. PBF, a Proto-oncogene in Esophageal Carcinoma.
    Lian SH; Song JD; Huang Y
    Open Med (Wars); 2019; 14():748-756. PubMed ID: 31637306
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study.
    Grande G; Milardi D; Martini M; Cenci T; Gulino G; Mancini F; Bianchi A; Pontecorvi A; Pierconti F
    Front Endocrinol (Lausanne); 2019; 10():619. PubMed ID: 31572301
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hypermethylation of the
    Tan X; Zhang S; Gao H; He W; Xu M; Wu Q; Ni X; Jiang H
    Oncol Lett; 2019 Aug; 18(2):1278-1286. PubMed ID: 31423188
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Novel Prognostic Factors Associated with Cell Cycle Control in Sporadic Medullary Thyroid Cancer Patients.
    Pezzani R; Bertazza L; Cavedon E; Censi S; Manso J; Watutantrige-Fernando S; Pennelli G; Galuppini F; Barollo S; Mian C
    Int J Endocrinol; 2019; 2019():9421079. PubMed ID: 30911297
    [TBL] [Abstract][Full Text] [Related]  

  • 69. PTTG1-interacting protein (PTTG1IP/PBF) predicts breast cancer survival.
    Repo H; Gurvits N; Löyttyniemi E; Nykänen M; Lintunen M; Karra H; Kurki S; Kuopio T; Talvinen K; Söderström M; Kronqvist P
    BMC Cancer; 2017 Oct; 17(1):705. PubMed ID: 29078751
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Functional consequences of the first reported mutations of the proto-oncogene PTTG1IP/PBF.
    Imruetaicharoenchoke W; Fletcher A; Lu W; Watkins RJ; Modasia B; Poole VL; Nieto HR; Thompson RJ; Boelaert K; Read ML; Smith VE; McCabe CJ
    Endocr Relat Cancer; 2017 Sep; 24(9):459-474. PubMed ID: 28676500
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pro-invasive Effect of Proto-oncogene PBF Is Modulated by an Interaction with Cortactin.
    Watkins RJ; Imruetaicharoenchoke W; Read ML; Sharma N; Poole VL; Gentilin E; Bansal S; Bosseboeuf E; Fletcher R; Nieto HR; Mallick U; Hackshaw A; Mehanna H; Boelaert K; Smith VE; McCabe CJ
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4551-4563. PubMed ID: 27603901
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prognostic implications of securin expression and sub-cellular localization in human breast cancer.
    Gurvits N; Repo H; Löyttyniemi E; Nykänen M; Anttinen J; Kuopio T; Talvinen K; Kronqvist P
    Cell Oncol (Dordr); 2016 Aug; 39(4):319-31. PubMed ID: 26984614
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Correlations of pituitary tumor transforming gene expression with human pituitary adenomas: a meta-analysis.
    Xiao JQ; Liu XH; Hou B; Yao Y; Deng K; Feng M; Xing B; Lian W; Wang RZ; Feng F
    PLoS One; 2014; 9(3):e90396. PubMed ID: 24594688
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The PTTG1-binding factor (PBF/PTTG1IP) regulates p53 activity in thyroid cells.
    Read ML; Seed RI; Fong JC; Modasia B; Ryan GA; Watkins RJ; Gagliano T; Smith VE; Stratford AL; Kwan PK; Sharma N; Dixon OM; Watkinson JC; Boelaert K; Franklyn JA; Turnell AS; McCabe CJ
    Endocrinology; 2014 Apr; 155(4):1222-34. PubMed ID: 24506068
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Are pre-miR-146a and PTTG1 associated with papillary thyroid cancer?
    Marino M; Cirello V; Gnarini V; Colombo C; Pignatti E; Casarini L; Diazzi C; Rochira V; Cioni K; Madeo B; Carani C; Simoni M; Fugazzola L
    Endocr Connect; 2013; 2(4):178-85. PubMed ID: 24145614
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Manipulation of PBF/PTTG1IP phosphorylation status; a potential new therapeutic strategy for improving radioiodine uptake in thyroid and other tumors.
    Smith VE; Sharma N; Watkins RJ; Read ML; Ryan GA; Kwan PP; Martin A; Watkinson JC; Boelaert K; Franklyn JA; McCabe CJ
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2876-86. PubMed ID: 23678037
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prognostic significance of pituitary tumour-transforming gene-binding factor (PBF) expression in papillary thyroid carcinoma.
    Hsueh C; Lin JD; Chang YS; Hsueh S; Chao TC; Yu JS; Jung SM; Tseng NM; Sun JH; Kuo SY; Ueng SH
    Clin Endocrinol (Oxf); 2013 Feb; 78(2):303-9. PubMed ID: 22888961
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Surgical treatment of papillary and follicular thyroid carcinoma.
    Lin JD; Jeng LB; Chao TC; Weng HF; Huang HS
    Int Surg; 1996; 81(1):61-6. PubMed ID: 8803709
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.
    Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH
    Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pituitary tumor transforming gene binding factor: a novel transforming gene in thyroid tumorigenesis.
    Stratford AL; Boelaert K; Tannahill LA; Kim DS; Warfield A; Eggo MC; Gittoes NJ; Young LS; Franklyn JA; McCabe CJ
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4341-9. PubMed ID: 15886233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.